Playback speed
10 seconds
ESMO 2022 on the Updated OS From the Phase 3 TOPAZ-1 Study: Durvalumab/Placebo + Gemcitabine & Cisplatin in Advanced Biliary Tract Cancer
By
ESMO 2022 Conference Coverage
FEATURING
Do-Youn Oh
By
ESMO 2022 Conference Coverage
FEATURING
Do-Youn Oh
167 views
September 19, 2022
Comments 0
Login to view comments.
Click here to Login